Publicaciones en las que colabora con EVA ALLONCA CAMPA (11)

2023

  1. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2019

  1. PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma

    Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554

  2. The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2017

  1. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma

    Head and Neck, Vol. 39, Núm. 9, pp. 1876-1887

2016

  1. Expression of the voltage-gated potassium channel Kv3.4 in oral leucoplakias and oral squamous cell carcinomas

    Histopathology, Vol. 69, Núm. 1, pp. 91-98

2015

  1. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival

    Virchows Archiv, Vol. 466, Núm. 5, pp. 549-558

2013

  1. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: Relations with clinical variables

    British Journal of Oral and Maxillofacial Surgery, Vol. 51, Núm. 2, pp. 149-156

  2. Focal adhesion kinase overexpression: Correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma

    Head and Neck, Vol. 35, Núm. 6, pp. 826-830

  3. Podoplanin expression in oral leukoplakia: Tumorigenic role

    Oral Oncology, Vol. 49, Núm. 6, pp. 598-603

2012

  1. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions

    Oral Oncology, Vol. 48, Núm. 7, pp. 641-646

2011

  1. Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma

    Head and Neck, Vol. 33, Núm. 12, pp. 1708-1714